A new era in aneuploidy screening: cfDNA testing in >30,000 multifetal gestations: Experience at one clinical laboratory

Aneuploidy screening options are limited for multifetal pregnancies but a recent meta-analysis has shown that cfDNA for Trisomy 21 is superior to conventional screening in this population (Reference obgyn.onlinelibrary.wiley.com/doi/full/10.1002/uog.20284). Our new study “A new era in aneuploidy screening: cfDNA testing in >30,000 multifetal gestations: experience at one clinical laboratory” details our extensive clinical laboratory experience with MaterniT21 PLUS screening in twins, triplets and higher order multiples.